Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections
- PMID: 20199244
- DOI: 10.1086/651430
Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections
Abstract
Microbial translocation has been linked to systemic immune activation during human immunodeficiency virus (HIV) type 1 infection. Here, we show that an elevated level of microbial translocation, measured as plasma lipopolysaccharide (LPS) concentration, correlates with AIDS in both individuals infected with HIV type 1 and individuals infected with HIV type 2. LPS concentration also correlates with CD4+ T cell count and viral load independently of HIV type. Furthermore, elevated plasma LPS concentration was found to be concomitant with defective innate and mitogen responsiveness. We suggest that microbial translocation may contribute to loss of CD4+ T cells, increase in viral load, and defective immune stimuli responsiveness during both HIV type 1 and HIV type 2 infections.
Comment in
-
Is microbial translocation a cause or consequence of HIV disease progression?J Infect Dis. 2011 Mar 1;203(5):744-5; author reply 746. doi: 10.1093/infdis/jiq107. Epub 2011 Jan 10. J Infect Dis. 2011. PMID: 21220777 Free PMC article. No abstract available.
Similar articles
-
Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.J Infect Dis. 2010 Sep 1;202(5):723-33. doi: 10.1086/655229. J Infect Dis. 2010. PMID: 20629534
-
Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.Ophthalmology. 2003 Feb;110(2):432-6. doi: 10.1016/S0161-6420(02)01750-5. Ophthalmology. 2003. PMID: 12578793
-
Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.AIDS. 2008 Oct 1;22(15):2035-8. doi: 10.1097/QAD.0b013e3283112d29. AIDS. 2008. PMID: 18784466
-
HIV disease progression: immune activation, microbes, and a leaky gut.Top HIV Med. 2007 Aug-Sep;15(4):114-7. Top HIV Med. 2007. PMID: 17720995 Review.
-
Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation.Front Immunol. 2019 Mar 18;10:465. doi: 10.3389/fimmu.2019.00465. eCollection 2019. Front Immunol. 2019. PMID: 30967860 Free PMC article. Review.
Cited by
-
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.J Virol. 2011 Jul;85(13):6557-66. doi: 10.1128/JVI.00073-11. Epub 2011 Apr 13. J Virol. 2011. PMID: 21490090 Free PMC article. Clinical Trial.
-
Translocation of microbes and changes of immunocytes in the gut of rapid- and slow-progressor Chinese rhesus macaques infected with SIVmac239.Immunology. 2016 Apr;147(4):443-52. doi: 10.1111/imm.12574. Epub 2016 Jan 28. Immunology. 2016. PMID: 26725773 Free PMC article.
-
The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review.Virol J. 2012 Aug 27;9:174. doi: 10.1186/1743-422X-9-174. Virol J. 2012. PMID: 22925532 Free PMC article.
-
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.PLoS One. 2015 Feb 26;10(2):e0117424. doi: 10.1371/journal.pone.0117424. eCollection 2015. PLoS One. 2015. PMID: 25719208 Free PMC article.
-
HIV treatment in Guinea-Bissau: room for improvement and time for new treatment options.AIDS Res Ther. 2020 Feb 4;17(1):3. doi: 10.1186/s12981-020-0259-6. AIDS Res Ther. 2020. PMID: 32019545 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials